DE-111 ophthalmic solution will be evaluated for superiority in comparison with Timolol
ophthalmic solution 0.5%, in IOP(intraocular pressure ) -lowering effect in primary
open-angle glaucoma or ocular hypertension patients, in a multicenter, randomized,
double-masked, parallel-group comparison study. Safety will be compared and evaluated as
well.